Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,301,372
-$5,810,570 QoQ
Shares Held
300,833
-64.0% QoQ
Ownership
0.358%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Derivatives in REPL
reported options exposure · as of Mar 31, 2026CallValue
$574,515
CallShares
75,100
PutValue
$822,375
PutShares
107,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. REPL ranks #239 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in REPL
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,301,372 | 300,833 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $574,515 | 75,100 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $822,375 | 107,500 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $8,111,942 | 834,562 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $1,458,000 | 150,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $1,257,000 | 300,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $6,661,031 | 1,589,745 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,376,761 | 794,054 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $3,833,983 | 412,700 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $696,750 | 75,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $11,926,551 | 1,223,236 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,406,806 | 1,189,662 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,656,838 | 1,154,821 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $28,062,315 | 3,118,035 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,773,412 | 461,862 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $126,669 | 15,026 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $233,568 | 13,651 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,377,931 | 403,873 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,383,391 | 587,961 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,493,491 | 275,496 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,385,211 | 138,113 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,782,365 | 101,966 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $225,205 | 13,263 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,813,684 | 103,826 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,621,124 | 88,432 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,594,417 | 119,584 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,923,529 | 95,822 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,189,431 | 214,664 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $254,278 | 11,046 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $594,231 | 59,602 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||